X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs FDC LTD. - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD FDC LTD. ALEMBIC LTD/
FDC LTD.
 
P/E (TTM) x 122.8 29.0 423.7% View Chart
P/BV x 4.6 6.0 75.5% View Chart
Dividend Yield % 0.2 0.8 31.4%  

Financials

 ALEMBIC LTD   FDC LTD.
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
FDC LTD.
Mar-14
ALEMBIC LTD/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs53144 36.8%   
Low Rs2979 37.1%   
Sales per share (Unadj.) Rs4.747.6 9.9%  
Earnings per share (Unadj.) Rs8.87.6 115.3%  
Cash flow per share (Unadj.) Rs9.09.0 99.9%  
Dividends per share (Unadj.) Rs0.152.25 6.7%  
Dividend yield (eoy) %0.42.0 18.1%  
Book value per share (Unadj.) Rs27.747.5 58.3%  
Shares outstanding (eoy) m267.03177.83 150.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x8.72.3 371.9%   
Avg P/E ratio x4.714.6 32.0%  
P/CF ratio (eoy) x4.612.3 36.9%  
Price / Book Value ratio x1.52.3 63.3%  
Dividend payout %1.729.6 5.8%   
Avg Mkt Cap Rs m10,96219,784 55.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2381,221 19.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2608,459 14.9%  
Other income Rs m264394 67.0%   
Total revenues Rs m1,5248,852 17.2%   
Gross profit Rs m832,070 4.0%  
Depreciation Rs m61249 24.6%   
Interest Rs m031 1.0%   
Profit before tax Rs m2852,184 13.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,096-225 -932.1%   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m6606 1.0%   
Profit after tax Rs m2,3431,353 173.1%  
Gross profit margin %6.624.5 26.8%  
Effective tax rate %2.127.7 7.7%   
Net profit margin %185.916.0 1,162.0%  
BALANCE SHEET DATA
Current assets Rs m1,6894,355 38.8%   
Current liabilities Rs m4861,792 27.1%   
Net working cap to sales %95.430.3 314.9%  
Current ratio x3.52.4 142.9%  
Inventory Days Days21744 488.0%  
Debtors Days Days8125 328.5%  
Net fixed assets Rs m1,6243,025 53.7%   
Share capital Rs m534179 299.0%   
"Free" reserves Rs m5,9608,243 72.3%   
Net worth Rs m7,4048,453 87.6%   
Long term debt Rs m10411 974.8%   
Total assets Rs m8,01010,557 75.9%  
Interest coverage x950.771.4 1,331.2%   
Debt to equity ratio x00 1,112.9%  
Sales to assets ratio x0.20.8 19.6%   
Return on assets %29.313.1 223.1%  
Return on equity %31.616.0 197.7%  
Return on capital %31.323.5 133.1%  
Exports to sales %2.913.3 22.1%   
Imports to sales %28.93.3 863.1%   
Exports (fob) Rs m371,126 3.3%   
Imports (cif) Rs m364283 128.6%   
Fx inflow Rs m371,146 3.2%   
Fx outflow Rs m365355 102.7%   
Net fx Rs m-328791 -41.5%   
CASH FLOW
From Operations Rs m3461,485 23.3%  
From Investments Rs m-48-620 7.7%  
From Financial Activity Rs m-301-753 40.0%  
Net Cashflow Rs m-3113 -2.7%  

Share Holding

Indian Promoters % 64.0 68.9 92.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.7 4.3%  
FIIs % 9.7 7.5 129.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 19.0 137.4%  
Shareholders   54,701 23,730 230.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  MERCK LTD  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 23, 2018 03:35 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - GSK PHARMA COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS